Herbert Klei
Molecular Biology · 2004–2018
A researcher in the Science corpus: 5 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 18 citations into it
- Materials Chemistry — 14 citations into it
- Computational Theory and Mathematics — 6 citations into it
Whom Herbert Klei trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Thomas J. Oldfield
- David Weininger
- Nigel W. Moriarty
- Paul D. Adams
- John E. Hopcroft
- T. C. Terwilliger
- R. Grosse-Kunstleve
- Luigi Pietro Cordella
- A. Lebedev
- Richard M. Karp
Papers from Herbert Klei's perspective
Ordered by how strongly the researchers Herbert Klei trusts endorse each paper. Same corpus, a different order for every researcher.
- High-resolution structure of a retroviral protease folded as a monomer
- Dauter electronic Ligand Builder and Optimization Workbench ( eLBOW ) : a tool for ligand coordinate and restraint generation
- On the treatment of negative intensity observations
- The penultimate rotamer library
- Retrieval of Crystallographically-Derived Molecular Geometry Information (Journal of Chemical Information and Modeling)
- A n^5/2 Algorithm for Maximum Matchings in Bipartite Graphs
- Automated ligand fitting by core-fragment fitting and extension into density
- Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features
- The RCSB Protein Data Bank: redesigned web site and web services
- Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database
Their papers
- Ligand placement based on prior structures: the guided ligand-replacement method (2013) — 13 citations
- Interactive comparison and remediation of collections of macromolecular structures (2018) — 14 citations
- Automated ligand fitting by core-fragment fitting and extension into density (2006)
- The structure of Dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants. (2006) — 660 citations
- Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. (2004) — 1,334 citations